Research
Immunologia i Inflamació

Immunologia de la Diabetis

Publications

  • Reyes, R, Moreno-Perez, O, Tejera-Perez, C, Brito-Sanfiel, M, Pines, P, Aguilera, E, Gargallo, M, Rozas-Moreno, P and Martin, JES.

    Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study

    DIABETES & METABOLISM 50(1):

    [doi:10.1016/j.diabet.2023.101496]

  • Perna-Barrull, D, Gomez-Munoz, L, Rodriguez-Fernandez, S, Gieras, A, Ampudia-Carrasco, RM, Almenara-Fuentes, L, Risueno, RM, Querol, S, Tolosa, E and Vives-Pi, M.

    Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells

    Archivum Immunologiae et Therapiae Experimentalis 71(1):

    [doi:10.1007/s00005-022-00666-5]

  • Gomez-Munoz, Laia, Dominguez-Bendala, Juan, Pastori, Ricardo L and Vives-Pi, Marta.

    Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM 35(2): 151-163

    [doi:10.1016/j.tem.2023.10.005]

  • Bellido, V, Aguilera, E, Cardona-Hernandez, R, Diaz-Soto, G, de Villar, NGP, Picón-César, MJ and Ampudia-Blasco, FJ.

    Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of diabetes science and technology 17(5): 1326-1336

    [doi:10.1177/19322968221088601]

  • Corral-Pujol, M, Arpa, B, Rosell-Mases, E, Egia-Mendikute, L, Mora, C, Stratmann, T, Sanchez, A, Casanovas, A, Esquerda, JE, Mauricio, D, Vives-Pi, M and Verdaguer, J.

    NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development

    Frontiers in Endocrinology 14:

    [doi:10.3389/fendo.2023.1176566]

  • Gomez-Munoz, L, Perna-Barrull, D, Murillo, M, Armengol, MP, Alcalde, M, Catala, M, Rodriguez-Fernandez, S, Sunye, S, Valls, A, Perez, J, Corripio, R and Vives-Pi, M.

    Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion

    Non-coding RNA 9(2):

    [doi:10.3390/ncrna9020017]

  • Salvia, R, Rico, LG, Bradford, JA, Ward, MD, Olszowy, MW, Martinez, C, Madrid-Aris, AD, Grifols, JR, Ancochea, A, Gomez-Munoz, L, Vives-Pi, M, Martinez-Caceres, E, Fernandez, MA, Sorigue, M and Petriz, J.

    Fast-screening flow cytometry method for detecting nanoplastics in human peripheral blood

    MethodsX 10:

    [doi:10.1016/j.mex.2023.102057]

  • Almenara-Fuentes, L, Rodriguez-Fernandez, S, Rosell-Mases, E, Kachler, K, You, AX, Salvado, M, Andreev, D, Steffen, U, Bang, H, Bozec, A, Schett, G, Le Panse, R, Verdaguer, J, Dalmases, M, Rodriguez-Vidal, S, Barneda-Zahonero, B and Vives-Pi, M.

    A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens

    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 48:

    [doi:10.1016/j.nano.2022.102635]

  • Perna-Barrull, D, Murillo, M, Real, N, Gomez-Munoz, L, Rodriguez-Fernandez, S, Bel, J, Puig-Domingo, M and Vives-Pi, M.

    Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort

    Journal of Diabetes Research 2022:

    [doi:10.1155/2022/6598600]

  • Gomez-Munoz, L, Perna-Barrull, D, Caroz-Armayones, JM, Murillo, M, Rodriguez-Fernandez, S, Valls, A, Vazquez, F, Perez, J, Corripio, R, Castano, L, Bel, J and Vives-Pi, M.

    Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

    Frontiers in Immunology 13:

    [doi:10.3389/fimmu.2022.825426]

  • Teniente-Serra, A, Pizarro, E, Quirant-Sanchez, B, Fernandez, MA, Vives-Pi, M and Martinez-Caceres, EM.

    Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes

    Frontiers in Immunology 12: 784110-784110

    [doi:10.3389/fimmu.2021.784110]

  • Rodriguez-Fernandez, S, Almenara-Fuentes, L, Perna-Barrull, D, Barneda, B and Vives-Pi, M.

    A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes

    Immunology and Cell Biology 99(5): 461-474

    [doi:10.1111/imcb.12439]

  • Gomez-Munoz, L, Perna-Barrull, D, Villalba, A, Rodriguez-Fernandez, S, Ampudia, RM, Teniente-Serra, A, Vazquez, F, Murillo, M, Perez, J, Corripio, R, Bel, J and Vives-Pi, M.

    NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes

    Frontiers in Immunology 11: 611522-611522

    [doi:10.3389/fimmu.2020.611522]

  • Villalba A, Rodriguez-Fernandez S, Ampudia RM, Cano-Sarabia M, Perna-Barrull D, Bertran-Cobo C, Ehrenberg C, Maspoch D and Vives-Pi M.

    Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.

    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 48(1): 77-83

    [doi:10.1080/21691401.2019.1699812]

  • Villalba, A, Rodriguez-Fernandez, S, Perna-Barrull, D, Ampudia, RM, Gomez-Munoz, L, Pujol-Autonell, I, Aguilera, E, Risueno, RM, Cano-Sarabia, M, Maspoch, D, Vazquez, F and Vives-Pi, M.

    Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes

    Scientific Reports 10(1): 18927-18927

    [doi:10.1038/s41598-020-76041-1]

  • Perna-Barrull, D, Gieras, A, Rodriguez-Fernandez, S, Tolosa, E and Vives-Pi, M.

    Immune System Remodelling by Prenatal Betamethasone: Effects on beta-Cells and Type 1 Diabetes

    Frontiers in Endocrinology 11: 540-540

    [doi:10.3389/fendo.2020.00540]

  • Villalba, A, Rodriguez-Fernandez, S, Perna-Barrull, D, Ampudia, RM, Gomez-Munoz, L, Pujol-Autonell, I, Aguilera, E, Coma, M, Cano-Sarabia, M, Vazquez, F, Verdaguer, J and Vives-Pi, M.

    Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming

    Frontiers in Endocrinology 11: 258-258

    [doi:10.3389/fendo.2020.00258]

  • Piquer-Garcia, I, Campderros, L, Taxeras, SD, Gavalda-Navarro, A, Pardo, R, Vila, M, Pellitero, S, Martinez, E, Tarasco, J, Moreno, P, Villarroya, J, Cereijo, R, Gonzalez, L, Reyes, M, Rodriguez-Fernandez, S, Vives-Pi, M, Lerin, C, Elks, CM, Stephens, JM, Puig-Domingo, M, Villarroya, F, Villena, JA and Sanchez-Infantes, D.

    A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 105(3): 337-348

    [doi:10.1210/clinem/dgz090]

  • Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernández R, Escalada FJ, Fernández D, Gómez-Peralta F, González Pérez de Villar N, Gorgojo JJ, Mezquita-Raya P, Morales C, de Pablos Velasco P, Palomares R, Parra J, Rivero MT and González-Blanco C.

    Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation.

    Journal of diabetes science and technology 14(1): 155-164

    [doi:10.1177/1932296819841911]

  • Rodriguez-Fernandez, S, Murillo, M, Villalba, A, Perna-Barrull, D, Cano-Sarabia, M, Gomez-Munoz, L, Aguilera, E, Maspoch, D, Vazquez, F, Bel, J and Vives-Pi, M.

    Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential

    Frontiers in Immunology 10: 2811-2811

    [doi:10.3389/fimmu.2019.02811]

  • Villalba, A, Fonolleda, M, Murillo, M, Rodriguez-Fernandez, S, Ampudia, RM, Perna-Barrull, D, Raina, MB, Quirant-Sanchez, B, Planas, R, Teniente-Serra, A, Bel, J and Vives-Pi, M.

    Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study

    Translational Research 210: 8-25

    [doi:10.1016/j.trsl.2019.03.002]

  • Egia-Mendikute, L, Arpa, B, Rosell-Mases, E, Corral-Pujol, M, Carrascal, J, Carrillo, J, Mora, C, Chapman, H, Panosa, A, Vives-Pi, M, Stratmann, T, Serreze, D and Verdaguer, J.

    B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes

    Frontiers in Immunology 10: 1732-1732

    [doi:10.3389/fimmu.2019.01732]

  • Deiss, D, Szadkowska, A, Gordon, D, Mallipedhi, A, Schutz-Fuhrmann, I, Aguilera, E, Ringsell, C, De Block, C and Irace, C.

    Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System

    DIABETES TECHNOLOGY & THERAPEUTICS 21(5): 254-264

    [doi:10.1089/dia.2018.0397]

  • Perna-Barrull, D, Rodriguez-Fernandez, S, Pujol-Autonell, I, Gieras, A, Ampudia-Carrasco, RM, Villalba, A, Glau, L, Tolosa, E and Vives-Pi, M.

    Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes

    Scientific Reports 9(1): 1235-1235

    [doi:10.1038/s41598-018-37878-9]